Cefapirin
Appearance
(Redirected from Ambrocef)
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601206 |
Routes of administration | Intravenous, intramuscular |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.040.409 |
Chemical and physical data | |
Formula | C17H17N3O6S2 |
Molar mass | 423.46 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Cefapirin (INN, also spelled cephapirin) is an injectable, first-generation cephalosporin antibiotic. It is marketed under the trade name Cefadyl. Production for use in humans has been discontinued in the United States.[1]
It also has a role in veterinary medicine as Metricure, an intrauterine preparation, and combined with prednisolone in Mastiplan, an intramammary preparation. Both are licensed in cattle.[citation needed]
Synthesis
[edit]In one of the syntheses, 7-aminocephalosporanic acid (7-ACA) is reacted with bromoacetyl chloride to give the amide. The halo group is then displaced by 4-thiopyridine.[2]